ProfileGDS4132 / 212420_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 69% 66% 71% 77% 70% 70% 72% 74% 75% 73% 71% 73% 71% 75% 80% 79% 76% 72% 74% 73% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101201.85669
GSM201543Muscle PCOS pioglitazone 121183.26266
GSM201544Muscle PCOS pioglitazone 161222.91271
GSM201545Muscle PCOS pioglitazone 201268.03877
GSM201829Muscle PCOS pioglitazone 231221.47770
GSM201830Muscle PCOS pioglitazon 251214.26270
GSM201831Muscle PCOS pioglitazone 271226.8772
GSM201832Muscle PCOS pioglitazone 31220.57474
GSM201833Muscle PCOS pioglitazone 41230.84275
GSM201834Muscle PCOS pioglitazone 81225.08873
GSM201835Muscle PCOS after pioglitazone 102211.19171
GSM201836Muscle PCOS after pioglitazone 122224.00273
GSM201837Muscle PCOS after pioglitazone 162198.81471
GSM201838Muscle PCOS after pioglitazone 202241.8775
GSM201839Muscle PCOS after pioglitazone 232287.71680
GSM201840Muscle PCOS after pioglitazone 252278.17879
GSM201841Muscle PCOS after pioglitazone 272235.12676
GSM201842Muscle PCOS after pioglitazone 32192.52472
GSM201843Muscle PCOS after pioglitazone 42229.21674
GSM201844Muscle PCOS after pioglitazone 82231.24373